SkyKnight Capital has entered into a definitive agreement to invest in Apex Infusion, according to a news release.
Apex, founded in 2006 and headquartered in Signal Hill, California, is an infusion provider that delivers therapies to patients across a network of ambulatory infusion suites and in-home care.
SkyKnight Capital, founded in 2015 and with locations in Burlingame, California and New York, is a private equity firm focused on healthcare and a few other sectors. The firm seeks to invest $25 million to $250 million or higher in companies to acquire 25% to 75% or higher equity ownership.
Apex’s management team will retain a significant ownership stake, and FFL Partners, an existing investor in the company, will remain a minority investor.
Terms of the investment were not disclosed.